130 related articles for article (PubMed ID: 16186364)
1. The influence of intraocular pressure on the transscleral diffusion of high-molecular-weight compounds.
Cruysberg LP; Nuijts RM; Geroski DH; Gilbert JA; Hendrikse F; Edelhauser HF
Invest Ophthalmol Vis Sci; 2005 Oct; 46(10):3790-4. PubMed ID: 16186364
[TBL] [Abstract][Full Text] [Related]
2. Diffusion of high molecular weight compounds through sclera.
Ambati J; Canakis CS; Miller JW; Gragoudas ES; Edwards A; Weissgold DJ; Kim I; Delori FC; Adamis AP
Invest Ophthalmol Vis Sci; 2000 Apr; 41(5):1181-5. PubMed ID: 10752958
[TBL] [Abstract][Full Text] [Related]
3. Diffusion of macromolecules through sclera.
Miao H; Wu BD; Tao Y; Li XX
Acta Ophthalmol; 2013 Feb; 91(1):e1-6. PubMed ID: 22998133
[TBL] [Abstract][Full Text] [Related]
4. Influence of molecular shape, conformability, net surface charge, and tissue interaction on transscleral macromolecular diffusion.
Srikantha N; Mourad F; Suhling K; Elsaid N; Levitt J; Chung PH; Somavarapu S; Jackson TL
Exp Eye Res; 2012 Sep; 102():85-92. PubMed ID: 22846670
[TBL] [Abstract][Full Text] [Related]
5. Permeability of retinal pigment epithelium: effects of permeant molecular weight and lipophilicity.
Pitkänen L; Ranta VP; Moilanen H; Urtti A
Invest Ophthalmol Vis Sci; 2005 Feb; 46(2):641-6. PubMed ID: 15671294
[TBL] [Abstract][Full Text] [Related]
6. The effect of intraocular pressure on human and rabbit scleral permeability.
Rudnick DE; Noonan JS; Geroski DH; Prausnitz MR; Edelhauser HF
Invest Ophthalmol Vis Sci; 1999 Nov; 40(12):3054-8. PubMed ID: 10549673
[TBL] [Abstract][Full Text] [Related]
7. Characterization of human sclera barrier properties for transscleral delivery of bevacizumab and ranibizumab.
Wen H; Hao J; Li SK
J Pharm Sci; 2013 Mar; 102(3):892-903. PubMed ID: 23212655
[TBL] [Abstract][Full Text] [Related]
8. Scleral hydraulic conductivity and macromolecular diffusion in patients with uveal effusion syndrome.
Jackson TL; Hussain A; Morley AM; Sullivan PM; Hodgetts A; El-Osta A; Hillenkamp J; Charles SJ; Sheard R; Williamson TH; Kumar A; Laidlaw DA; Woon WH; Costen MJ; Luff AJ; Marshall J
Invest Ophthalmol Vis Sci; 2008 Nov; 49(11):5033-40. PubMed ID: 18552396
[TBL] [Abstract][Full Text] [Related]
9. In vivo ocular fluorophotometry: delivery of fluoresceinated dextrans via transscleral diffusion in rabbits.
Berezovsky DE; Patel SR; McCarey BE; Edelhauser HF
Invest Ophthalmol Vis Sci; 2011 Sep; 52(10):7038-45. PubMed ID: 21791594
[TBL] [Abstract][Full Text] [Related]
10. Human scleral permeability. Effects of age, cryotherapy, transscleral diode laser, and surgical thinning.
Olsen TW; Edelhauser HF; Lim JI; Geroski DH
Invest Ophthalmol Vis Sci; 1995 Aug; 36(9):1893-903. PubMed ID: 7543465
[TBL] [Abstract][Full Text] [Related]
11. Effect of benzalkonium chloride on transscleral drug delivery.
Okabe K; Kimura H; Okabe J; Kato A; Shimizu H; Ueda T; Shimada S; Ogura Y
Invest Ophthalmol Vis Sci; 2005 Feb; 46(2):703-8. PubMed ID: 15671302
[TBL] [Abstract][Full Text] [Related]
12. Transscleral permeability of fluorescent-labeled antibiotics.
Kao JC; Geroski DH; Edelhauser HF
J Ocul Pharmacol Ther; 2005 Feb; 21(1):1-10. PubMed ID: 15718823
[TBL] [Abstract][Full Text] [Related]
13. Human scleral hydraulic conductivity: age-related changes, topographical variation, and potential scleral outflow facility.
Jackson TL; Hussain A; Hodgetts A; Morley AM; Hillenkamp J; Sullivan PM; Marshall J
Invest Ophthalmol Vis Sci; 2006 Nov; 47(11):4942-6. PubMed ID: 17065511
[TBL] [Abstract][Full Text] [Related]
14. Human transscleral albumin permeability and the effect of topographical location and donor age.
Anderson OA; Jackson TL; Singh JK; Hussain AA; Marshall J
Invest Ophthalmol Vis Sci; 2008 Sep; 49(9):4041-5. PubMed ID: 18450593
[TBL] [Abstract][Full Text] [Related]
15. Scleral permeability of a small, single-stranded oligonucleotide.
Shuler RK; Dioguardi PK; Henjy C; Nickerson JM; Cruysberg LP; Edelhauser HF
J Ocul Pharmacol Ther; 2004 Apr; 20(2):159-68. PubMed ID: 15117572
[TBL] [Abstract][Full Text] [Related]
16. Small Intestinal Permeability and Gut-Transit Time Determined with Low and High Molecular Weight Fluorescein Isothiocyanate-Dextrans in C3H Mice.
Woting A; Blaut M
Nutrients; 2018 May; 10(6):. PubMed ID: 29843428
[TBL] [Abstract][Full Text] [Related]
17. Dextran retention in the rat brain following release from a polymer implant.
Dang W; Saltzman WM
Biotechnol Prog; 1992; 8(6):527-32. PubMed ID: 1282018
[TBL] [Abstract][Full Text] [Related]
18. Scleral permeability varies by mouse strain and is decreased by chronic experimental glaucoma.
Pease ME; Oglesby EN; Cone-Kimball E; Jefferys JL; Steinhart MR; Kim AJ; Hanes J; Quigley HA
Invest Ophthalmol Vis Sci; 2014 Apr; 55(4):2564-73. PubMed ID: 24557355
[TBL] [Abstract][Full Text] [Related]
19. Intraocular distribution of 70-kDa dextran after subconjunctival injection in mice.
Kim TW; Lindsey JD; Aihara M; Anthony TL; Weinreb RN
Invest Ophthalmol Vis Sci; 2002 Jun; 43(6):1809-16. PubMed ID: 12036983
[TBL] [Abstract][Full Text] [Related]
20. Increased human scleral permeability with prostaglandin exposure.
Kim JW; Lindsey JD; Wang N; Weinreb RN
Invest Ophthalmol Vis Sci; 2001 Jun; 42(7):1514-21. PubMed ID: 11381055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
